Endoparasitic VR

Miziziziz · 2023 · $19.99 · Action · deal grade B

Measured on 2026-09-24 06:15 UTC, 12 days ago. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

• Estimated net residual revenue: $193 to $290 per month
• Opportunity: $399 per month at x1.65 dormancy
• Estimated lifetime owners: 1.3k
• 88% positive across 33 reviews · 1.9 reviews/month

Why it's flagged

• Developer silent for 22 months
• Studio active elsewhere (6 titles tracked), so this one may welcome a partner
• Store page localized in only 1 language(s)

Analyst notes (AI-assisted)

Note written 2026-09-18; the live figures above take precedence over any numbers in it.

A VR port of the 2D action game Endoparasitic that uses mouth-based reload mechanics in a faithful 3D translation.

This is a niche, quiet title with strong positive sentiment among its small installed base but virtually no current traction: zero players in the last 30 days and no discount activity in 22 months suggest the port launched and stalled. The opportunity lies not in residual revenue, which is modest, but in understanding why a faithful, well-reviewed VR adaptation failed to find an audience, and whether revival (localization, platform expansion, marketing refresh) or licensing its VR mechanics could unlock value elsewhere. Most realistic play: watch.

• Risk: VR platform fragmentation and headset adoption volatility may have narrowed addressable market below what flat-screen action fans would reach.
• Risk: Endoparasitic is a dormant IP with no parent franchise momentum; VR ports of obscure 2D games face inherent discoverability headwinds.
• Risk: Developer has posted no public updates in 22 months and run zero promotions, signaling possible resource constraints or deprioritization.

This case as Markdown · Estimates carry ±30-50% error per title.